Tyrosine-derived nanospheres for enhanced topical skin penetration

International Journal of Pharmaceutics

Volumn 350, Issue 1-2, 2008, Pages 312-319

  Sheihet, L ^a   Chandra, P ^a   Batheja, P ^b   Devore, D ^a   Kohn, J ^a   Michniak, B ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Biodegradable nanospheres; Fluorescence; Lipophilic; Skin penetration; Topical delivery

Indexed keywords

5 DODECANOYLAMINOFLUORESCEIN; COPOLYMER; DESAMINOTYROSYLTYROSINE ESTER DERIVATIVE; ESTER DERIVATIVE; FLUORESCENT DYE; MACROGOL; NANOSPHERE; NILE RED DYE; OLIGOMER; SUBERIC ACID; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG STRUCTURE; FLUORESCENCE MICROSCOPY; HUMAN; HYDRODYNAMICS; LIPOPHILICITY; NANOENCAPSULATION; PRIORITY JOURNAL; SKIN PENETRATION; TRANSMISSION ELECTRON MICROSCOPY;

ADMINISTRATION, CUTANEOUS; CHEMISTRY, PHARMACEUTICAL; HUMANS; NANOSPHERES; PERMEABILITY; SKIN ABSORPTION; TYROSINE;

EID: 38349147303     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.08.022     Document Type: Article

References (35)

1. Alvarez-Roman R., Naik A., Kalia Y.N., Guy R.H., and Fessi H. Enhancement of topical delivery from biodegradable nanoparticles. Pharm. Res. 21 (2004) 1818-1825
2. Barry B.W. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci. 14 (2001) 101-114
3. Barry B.W. Breaching the skin's barrier to drugs. Nat. Biotechnol. 22 (2004) 192-197
4. Bendas B., Schmalfuβ U., and Neubert R. Influence of propylene glycol as cosolvent on mechanisms of drug transport from hydrogels. Int. J. Pharm. 116 (1995) 19-30
5. Berthold A., Cremer K., and Kreuter J. Collagen microparticles: carriers for glucocorticosteroids. Eur. J. Pharm. Biopharm. 45 (1998) 23-29
6. Borgia S.L., Regehly M., Sivaramakrishnan R., Mehnert W., Korting H.C., Danker K., Roder B., Kramer K.D., and Schafer-Korting M. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J. Controlled Release 110 (2005) 151-163
7. Bourke S.L., and Kohn J. Polymers derived from the amino acid l-tyrosine: polycarbonates, polyarylates and copolymers with poly(ethylene glycol). Adv. Drug Del. Rev. 55 (2003) 447-466
8. Brown M.B., Martin G.P., Jones S.A., and Akomeah F.K. Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv. 13 (2006) 175-187
9. Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv. Drug Deliv. Rev. 56 (2004) 675-711
10. Chen H., Chang X., Du D., Liu W., Liu J., Weng T., Yang Y., Xu H., and Yang X. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J. Controlled Release 110 (2006) 296-306
11. De Jalon E.G., Blanco-Prieto M.J., Ygartua P., and Santoyo S. PLGA microparticles: possible vehicles for topical drug delivery. Int. J. Pharm. 226 (2001) 181-184
12. El Maghraby G.M., Williams A.C., and Barry B.W. Can drug-bearing liposomes penetrate intact skin?. J. Pharm. Pharmacol. 58 (2006) 415-429
13. Elias P.M., Feingold K.R., and Tsai J. Metabolic approach to transdermal drug delivery. In: Guy R.H., and Hadgraft J. (Eds). Transdermal drug delivery. second ed. (2003), Marcel Dekker, New York
14. Godin B., and Touitou E. Ethosomes: new prospects in transdermal delivery. Crit. Rev. Ther. Drug Carrier Syst. 20 (2003) 63-102
15. Greenwald R.B., Choe Y.H., Mcguire J., and Conover C.D. Effective drug delivery by PEGylated drug conjugates. Adv. Drug Deliv. Rev. 55 (2003) 217-250
16. Gupta S.P., and Jain S.K. Development of matrix-membrane transdermal drug delivery system for atenolol. Drug Deliv. 11 (2004) 281-286
17. Harris J.R., Roos C., Djalali R., Rheingans O., Maskos M., and Schmidt M. Application of the negative staining technique to both aqueous and organic solvent solutions of polymer particles. Micron 30 (1999) 289-298
18. Hatanakaa T., Shimoyamaa M., Sugibayashia K., and Morimotoa Y. Effect of vehicle on the skin permeability of drugs: polyethylene glycol 400-water and ethanol-water binary solvents. J. Controlled Release 23 (1993) 247-260
19. Liu J., Hu W., Chen H., Ni Q., Xu H., and Yang X. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int. J. Pharm. 328 (2007) 191-195
20. Man M.Q., Feingold K.R., and Elias P.M. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch. Dermatol. 129 (1993) 728-738
21. Meidan V.M., Al-Khalili M., and Michniak B.B. Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers. Int. J. Pharm. 264 (2003) 73-83
22. Muller R.H., Radtke M., and Wissing S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54 (2002) S131-S155
23. Nardin C., Bolikal D., and Kohn J. Nontoxic block copolymer nanospheres: design and characterization. Langmuir 20 (2004) 11721-11725
24. Pellet M., Raghavan S.L., Hadgraft J., and Davis A.F. The application of supersaturated systems to percutaneous drug delivery. In: Guy R.H., and Hadgraft J. (Eds). Transdermal drug delivery. second ed. (2003), Marcel Dekker, New York
25. Pillai O., Kumar N., Dey C.S., Borkute, Sivaprasad N., and Panchagnula R. Transdermal iontophoresis of insulin: III. Influence of electronic parameters. Methods Find Exp. Clin. Pharmacol. 26 (2004) 399-408
26. Ruben G.C. Quantification of particle sizes with metal replication under standard freeze-etching conditions: a gold ball standard for calibrating shadow widths was used to measure freeze-etch globular proteins. Microsc. Res. Tech. 32 (1995) 312-329
27. Santoyo S., Ga De Jalon E., Ygartua P., Renedo M.J., and Blanco-Prieto M.J. Optimization of topical cidofovir penetration using microparticles. Int. J. Pharm. 242 (2002) 107-113
28. Savic R., Luo L., Eisenberg A., and Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 303 (2004) 626-628
29. Sheihet L., Dubin R.A., Devore D., and Kohn J. Hydrophobic drug delivery by self-assembling triblock copolymer-derived nanospheres. Biomacromolecules 6 (2005) 2726-2731
30. Sheihet L., Kohn J., Devore D., Rubin E.H., and Gounder M.K. Development of a Novel Biodegradable Nanospheres-Paclitaxel Formulation as a Potential Anti-Cancer Agent: Evaluation of Toxicity and Efficacy in Comparison with Cremophor-Based Paclitaxel (2007), The Annual Retreat on Cancer Research in New Jersey, New Jersey
31. Sheihet L., Piotrowska K., Dubin R.A., Kohn J., and Devore D. Effect of tyrosine-derived triblock copolymer compositions on nanosphere self-assembly and drug delivery. Biomacromolecules 8 (2007) 998-1003
32. Vila A., Sanchez A., Perez C., and Alonso M.J. PLA-PEG nanospheres: new carriers for transmucosal delivery of proteins and plasmid DNA. Polym. Adv. Technol. 13 (2002) 851-858
33. Walker R.B., and Smith E.W. The role of percutaneous penetration enhancers. Adv. Drug Deliv. Rev. 18 (1996) 295-301
34. Ward A.J.P., and Osborne D.W. Hydrotropy and Penetration Enhancement. Pharmaceutical Skin Penetration Enhancement (1993), Marcel Dekker Inc., New York
35. Williams A.C., and Barry B.W. Penetration enhancers. Adv. Drug Deliv. Rev. 56 (2004) 603-618